2Dyck P J, Albers JW, Andersen H, et al. Diabetic polyneuropathies: update on research definition, diagn- ostic criteria and estimation of severity [ J 1. Diabetes Metab Res Rev, 2011,27(7) : 620-628.
3Boulton A, Vinik AI, Mezzo JC, et al. Diabeticneuropathies: a statement by the American Diabetes Association[J].Diabetes Care, 2005,28 (4) : 956 - 962.
4Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: response to the International Expert Committee [J].Diabetes Care, 2009,32(12) : 159 - 160.
5Kroin JS, Buvanendran A, Tuman KJ, et al. Safety of local anesthetics administered intrathecaUy in diabetic rats[J]. Pain Med, 2012, 13(6) : 802 -807.
6Echevarria M, Hachero A, Martinez A, et al. Spinal anaesthesia with 0. 5 % isobaric bupivacaine in patients with diabetes mellitus: the influence of CSF composi- tion on sensory and motor block [J].Euro J Anaesthesiol, 2008,25(12) : 1014 - 1019.
7Thornton P, Shannon J, Loane H, et al. Spinal anesthesia with 0. 5% isobaric bupivacalne in patients with diabetes mellitus: the influence of CSF composition on sensory and motor block [ J ]. Eur J Anaesthesiol, 2009,26(8): 710-711.
8Angadi DS, Garde A. Subclinical neuropathy in diabetic patients: a risk factor for bilateral lower limb neurological deficit following spinal anesthesia ? [ J ] .J Anesth, 2012,26(1) : 107 - 110.
9A1-Nasser B. Early involvement of spinal cord in diabetic peripheral neuropathy may influence patient outcome after neuraxial anesthesia [J].J Anesth, 2012,26(6) : 951 -952.
10Tesfaye S, Selvarajah D. Advances in the epidemio- logy, pathogenesis and management of diabetic periph- eral neuropathy [J]. Diabetes Metab Res Rev, 2012 (51): 8-14.
